Lab Offers New Generation Sequencing Test for Wound Microorganisms
By LabMedica International staff writers Posted on 06 Jun 2016 |
Image: The Wound~Seq test does not rely on bacterial culture, but rather uses state-of-the-art DNA sequencing technology to identify all bacteria present in the wound (Photo courtesy of Granger Diagnostics).
DNA sequencing technology underlies a new diagnostic service that claims to identify all bacteria, fungi, and parasites as well as select viruses in a wound or infected area.
The "Wound~Seq" test, which is performed on swab samples taken from the affected area, is available through Granger Diagnostics (Richmond, VA, USA). Samples collected by the doctor are sent to Granger's laboratory, and results are usually returned within 48 hours.
The Wound~Seq assay utilizes state-of-the-art DNA sequencing technology to identify all microorganisms present in the wound and does not rely on culture methods. It is the second Next-Generation Care Test in Granger Diagnostics' pipeline, following Gynecologene, a test for bacterial vaginosis that incorporates this DNA sequencing technology.
Dr. David G. Bostwick, chief medical officer at Granger Diagnostics, said, "We are excited to make available, for the first time, our clinically- significant test, Wound~Seq, that utilizes next-generation sequencing of the skin microbiome. Wounds and infections afflict millions of Americans every year, and are often perplexing to treat owing to the presence of unknown pathogens. Our new validated test provides significant actionable information that assists physicians in managing infections. Previous studies have shown that wound closure that relies on genetic-assisted testing is much more rapid, decreases pain and suffering, and results in cost savings. The promise of personalized medicine is now fulfilled."
Related Links:
Granger Diagnostics
The "Wound~Seq" test, which is performed on swab samples taken from the affected area, is available through Granger Diagnostics (Richmond, VA, USA). Samples collected by the doctor are sent to Granger's laboratory, and results are usually returned within 48 hours.
The Wound~Seq assay utilizes state-of-the-art DNA sequencing technology to identify all microorganisms present in the wound and does not rely on culture methods. It is the second Next-Generation Care Test in Granger Diagnostics' pipeline, following Gynecologene, a test for bacterial vaginosis that incorporates this DNA sequencing technology.
Dr. David G. Bostwick, chief medical officer at Granger Diagnostics, said, "We are excited to make available, for the first time, our clinically- significant test, Wound~Seq, that utilizes next-generation sequencing of the skin microbiome. Wounds and infections afflict millions of Americans every year, and are often perplexing to treat owing to the presence of unknown pathogens. Our new validated test provides significant actionable information that assists physicians in managing infections. Previous studies have shown that wound closure that relies on genetic-assisted testing is much more rapid, decreases pain and suffering, and results in cost savings. The promise of personalized medicine is now fulfilled."
Related Links:
Granger Diagnostics
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia